Picture of InVivo Therapeutics Holdings logo

NVIVQ — InVivo Therapeutics Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Brief: Invivo Therapeutics Reports Q2 Loss Per Share Of $7.48

Aug 7 (Reuters) - InVivo Therapeutics Holdings Corp
 NVIV.O :
    * INVIVO THERAPEUTICS REPORTS 2018 SECOND QUARTER FINANCIAL
RESULTS
    * Q2 LOSS PER SHARE $7.48

Source text for Eikon:  ID:nBw7QVYm9a 
Further company coverage:  NVIV.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on InVivo Therapeutics Holdings

See all news